A detailed history of Summit X, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Summit X, LLC holds 293 shares of REGN stock, worth $270,456. This represents 0.07% of its overall portfolio holdings.

Number of Shares
293
Previous 288 1.74%
Holding current value
$270,456
Previous $277,000 10.83%
% of portfolio
0.07%
Previous 0.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $4,416 - $5,355
5 Added 1.74%
293 $307,000
Q1 2024

May 08, 2024

SELL
$902.69 - $993.35 $492,868 - $542,369
-546 Reduced 65.47%
288 $277,000
Q4 2023

Feb 08, 2024

SELL
$775.18 - $881.7 $13,953 - $15,870
-18 Reduced 2.11%
834 $732,000
Q3 2023

Nov 03, 2023

SELL
$692.45 - $844.37 $6,232 - $7,599
-9 Reduced 1.05%
852 $701,000
Q2 2023

Aug 09, 2023

SELL
$700.03 - $830.35 $51,102 - $60,615
-73 Reduced 7.82%
861 $618,000
Q1 2023

May 10, 2023

SELL
$680.49 - $826.97 $8,165 - $9,923
-12 Reduced 1.27%
934 $767,000
Q4 2022

Feb 02, 2023

SELL
$705.89 - $766.39 $705 - $766
-1 Reduced 0.11%
946 $682,000
Q3 2022

Nov 01, 2022

BUY
$573.97 - $724.32 $573 - $724
1 Added 0.11%
947 $654,000
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $49,899 - $67,234
-91 Reduced 8.78%
946 $558,000
Q1 2022

May 05, 2022

SELL
$595.12 - $698.43 $435,627 - $511,250
-732 Reduced 41.38%
1,037 $720,000
Q4 2021

Jan 19, 2022

SELL
$543.48 - $670.97 $34,782 - $42,942
-64 Reduced 3.49%
1,769 $1.12 Million
Q3 2021

Oct 19, 2021

SELL
$574.03 - $680.96 $297,921 - $353,418
-519 Reduced 22.07%
1,833 $1.11 Million
Q2 2021

Jul 16, 2021

BUY
$472.8 - $558.54 $9,456 - $11,170
20 Added 0.86%
2,352 $1.31 Million
Q1 2021

May 10, 2021

BUY
$446.73 - $548.2 $283,673 - $348,107
635 Added 37.42%
2,332 $1.1 Million
Q4 2020

Jan 29, 2021

BUY
$478.3 - $607.98 $443,384 - $563,597
927 Added 120.39%
1,697 $810,000
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $14,163 - $17,113
26 Added 3.49%
770 $39.7 Million
Q2 2020

Aug 13, 2020

SELL
$493.32 - $643.92 $108,037 - $141,018
-219 Reduced 22.74%
744 $464,000
Q1 2020

May 13, 2020

BUY
$336.18 - $494.43 $1,680 - $2,472
5 Added 0.52%
963 $465,000
Q4 2019

Jan 23, 2020

SELL
$274.13 - $376.51 $38,926 - $53,464
-142 Reduced 12.91%
958 $361,000
Q3 2019

Oct 15, 2019

BUY
$273.46 - $318.39 $14,766 - $17,193
54 Added 5.16%
1,100 $310,000
Q2 2019

Aug 13, 2019

BUY
$299.6 - $414.82 $56,624 - $78,400
189 Added 22.05%
1,046 $309,000
Q1 2019

May 13, 2019

BUY
$372.08 - $439.57 $318,872 - $376,711
857 New
857 $352,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $98.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Summit X, LLC Portfolio

Follow Summit X, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.